XML 26 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Financing Arrangements
 3 Months Ended
Jul. 25, 2025
Debt Disclosure [Abstract]  
Financing Arrangements

6. Financing Arrangements

Long-Term Debt

The following table summarizes information relating to our long-term debt, which we collectively refer to as our Senior Notes (in millions, except interest rates):

 

 

Effective Interest Rate

 

July 25, 2025

 

 

April 25, 2025

 

1.875% Senior Notes Due June 2025

 

2.03%

 

$

—

 

 

$

750

 

2.375% Senior Notes Due June 2027

 

2.51%

 

 

550

 

 

 

550

 

2.70% Senior Notes Due June 2030

 

2.81%

 

 

700

 

 

 

700

 

5.50% Senior Notes Due June 2032

 

5.71%

 

 

625

 

 

 

625

 

5.70% Senior Notes Due June 2035

 

5.90%

 

 

625

 

 

 

625

 

Total principal amount

 

 

 

 

2,500

 

 

 

3,250

 

Unamortized discount and issuance costs

 

 

 

 

(15

)

 

 

(15

)

Total senior notes

 

 

 

 

2,485

 

 

 

3,235

 

Less: Current portion of long-term debt

 

 

 

 

—

 

 

 

(750

)

Total long-term debt

 

 

 

$

2,485

 

 

$

2,485

 

 

Senior Notes

On June 23, 2025, upon maturity, we repaid the 1.875% Senior Notes due June 2025 for an aggregate amount of $757 million, comprised of the principal and unpaid interest.

Our Senior Notes, which are unsecured, unsubordinated obligations, rank equally in right of payment with any existing and future senior unsecured indebtedness. Interest on our Senior Notes is payable semi-annually.

We may redeem the Senior Notes in whole or in part, at any time at our option at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, we may be required to repurchase the Senior Notes under specified terms. The Senior Notes also include covenants that limit our ability to incur debt secured by liens on assets or on shares of stock or indebtedness of our subsidiaries; to engage in certain sale and lease-back transactions; and to consolidate, merge or sell all or substantially all of our assets. As of July 25, 2025, we were in compliance with all covenants associated with the Senior Notes.

As of July 25, 2025, our aggregate future principal debt maturities are as follows (in millions):

Fiscal Year

 

Amount

 

2026

 

$

—

 

2027

 

 

—

 

2028

 

 

550

 

2029

 

 

—

 

2030

 

 

—

 

Thereafter

 

 

1,950

 

Total

 

$

2,500

 

Commercial Paper Program and Credit Facility

We have a commercial paper program (the Program), under which we may issue unsecured commercial paper notes. Amounts available under the Program, as amended in July 2017, may be borrowed, repaid and re-borrowed, with the aggregate face or principal amount of the notes outstanding under the Program at any time not to exceed $1.0 billion. The maturities of the notes can vary, but may not exceed 397 days from the date of issue. The notes are sold under customary terms in the commercial paper market and may be issued at a discount from par or, alternatively, may be sold at par and bear interest at rates dictated by market conditions at the time of their issuance. The proceeds from the issuance of the notes are used for general corporate purposes. There were no commercial paper notes outstanding as of July 25, 2025 or April 25, 2025.

 

In connection with the Program, we have a senior unsecured credit agreement with a syndicated group of lenders. The credit agreement, which was amended in March 2025, provides for a $1.0 billion revolving unsecured credit facility, with a sublimit of $50 million available for the issuance of letters of credit on our behalf. The credit facility matures on March 5, 2030, with an option for us to extend the maturity date for two additional 1-year periods, subject to certain conditions. The proceeds of the loans may be used by us for general corporate purposes and as liquidity support for our existing commercial paper program. As of July 25, 2025, we were compliant with all associated covenants in the agreement. No amounts were drawn against this credit facility during any of the periods presented.